NADMED technology was used in a clinical case study about an adult patient diagnosed with NADSYN1 associated congenital NAD deficiency. Research conducted at Danish university hospitals showed a deficiency in the patient’s NAD pool compared to his healthy siblings.
For the NAD measuring researchers collected blood from the fasting patient and his siblings. The vacutainers were then shipped to the NADMED laboratory where two NAD metabolites were extracted and measured. The abstract of the newly published study using the NADMED method can be read here.